ResMed improves revenues in Q1

Medical device maker ResMed said it increased its Q1 revenue
by 6 per cent as it released new products to the sleep therapy market.

The Business Spectator reports that the company’s revenue
for the period until September was $US380 million ($433.84 million) and its net
income came in at $US83.3 million ($95.1 million).

“Our results showed very strong performance from our
European and Asia-Pacific regions, as well as solid growth in the
Americas,” ResMed chief executive Mick Farrell said said.

“We are delivering on our promise to drive top-line
revenue growth this fiscal year by launching a strong portfolio of new
products, services, and solutions.”

According to the SMH, the result was bolstered by ResMed’s release of its AirSense 10 platform during the
quarter. This included the company’s first new ventilation machine in some
time.

“We are delivering on our promise to drive top-line
revenue growth this fiscal year by launching a strong portfolio of new
products, services, and solutions,” Chief executive Mick Farrell said in a statement.